STOCKHOLDERS’ EQUITY (Tables)
|
9 Months Ended |
Jun. 30, 2026 |
|---|
| Equity [Abstract] |
|
| Schedule of Stock-based Compensation Expense Related to Stock Options and RSUs |
The following table summarizes stock-based compensation expense related to restricted stock units (“RSUs”), performance-based restricted stock unit awards (“Performance RSUs”), stock options, and Employee Stock Purchase Plan (“ESPP”) shares, which was allocated as follows (amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Nine Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Cost of revenue | $ | 327 | | | $ | 181 | | | $ | 990 | | | $ | 504 | | | Selling and marketing | 976 | | | 950 | | | 2,167 | | | 2,959 | | | Research and development | 604 | | | 1,287 | | | 851 | | | 3,749 | | | General and administrative | 2,983 | | | 2,004 | | | 8,574 | | | 6,027 | | | Stock-based compensation expense | $ | 4,890 | | | $ | 4,422 | | | $ | 12,582 | | | $ | 13,239 | |
|
| Schedule of Stock Option Activity |
The following table summarizes stock option activity under the Company’s equity plans during the nine months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted-Average Exercise Price | | Weighted-Average Remaining Contractual Term (in years) | | Aggregate Intrinsic Value (in thousands) | | Outstanding at September 30, 2025 | 158,589 | | | $ | 9.28 | | | 4.8 | | $ | 204 | | | Granted | — | | | — | | | | | | | Exercised | (158,589) | | | 9.28 | | | | | 814 | | | Canceled | — | | | — | | | | | | | Outstanding at June 30, 2026 | — | | | — | | | 0 | | — | | | Vested at June 30, 2026 | — | | | — | | | 0 | | — | | | Exercisable at June 30, 2026 | — | | | — | | | 0 | | — | |
|
| Schedule of RSU Activity |
The following table summarizes RSU activity under the Company’s equity plans during the nine months ended June 30, 2026: | | | | | | | | | | | | | Number of Shares | | Weighted-Average Fair Market Value Per Share | | Outstanding at September 30, 2025 | 2,926,842 | | | $ | 9.94 | | | Granted | 1,575,644 | | | 9.61 | | | Settled | (770,943) | | | 10.29 | | | Canceled | (440,124) | | | 9.70 | | | Outstanding at June 30, 2026 | 3,291,419 | | | 9.73 | |
|
| Schedule of Performance RSU Activity |
The following table summarizes Performance RSU activity under the Company’s equity plans during the nine months ended June 30, 2026: | | | | | | | | | | | | | Number of Shares | | Weighted-Average Fair Market Value Per Share | | Outstanding at September 30, 2025 | 2,022,284 | | | $ | 9.49 | | | Granted | 1,125,938 | | | 8.68 | | | Settled | (640,232) | | | 11.44 | | | Canceled | (292,210) | | | 10.12 | | | Outstanding at June 30, 2026 | 2,215,780 | | | 8.44 | |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table shows the components of accumulated other comprehensive income (loss), net of income taxes, as of June 30, 2026 and September 30, 2025 (amounts in thousands): | | | | | | | | | | | | | June 30, 2026 | | September 30, 2025 | Unrealized gain (loss) on available-for-sale debt securities | $ | (2) | | | $ | 48 | | Foreign currency translation adjustments | (2,746) | | | 538 | | Total accumulated other comprehensive income (loss) | $ | (2,748) | | | $ | 586 | |
|